Phase 1b Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of SPI-1005 in Meniere's Disease

Trial Profile

Phase 1b Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of SPI-1005 in Meniere's Disease

Active, no longer recruiting
Phase of Trial: Phase I/II

Latest Information Update: 27 Jun 2017

At a glance

  • Drugs Ebselen (Primary)
  • Indications Meniere's disease
  • Focus Adverse reactions
  • Sponsors Sound Pharmaceuticals
  • Most Recent Events

    • 27 Jun 2017 According to a Sound Pharmaceuticals media release, status changed from recruiting to active, no longer recruiting.
    • 11 Dec 2015 Status changed from not yet recruiting to recruiting, as reported by ClinicalTrials.gov.
    • 17 Nov 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top